Inotuzumab ozogamicin and donor lymphocyte infusion is a safe and promising combination in relapsed acute lymphoblastic leukemia after allogeneic stem cell transplant.
Hematol Oncol
; 39(4): 580-583, 2021 Oct.
Article
in En
| MEDLINE
| ID: mdl-33963566
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Salvage Therapy
/
Lymphocyte Transfusion
/
Stem Cell Transplantation
/
Precursor Cell Lymphoblastic Leukemia-Lymphoma
/
Inotuzumab Ozogamicin
/
Neoplasm Recurrence, Local
Type of study:
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Adolescent
/
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Hematol Oncol
Year:
2021
Document type:
Article